OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PCR59

PCC Rokita SA

Specialty ChemicalsVerified

PCC Rokita maintains a conservative capital structure with a debt-to-equity ratio of 0.4, below the median for the Specialty Chemicals industry, and a current ratio of 1.47, indicating moderate liquidity. However, the company reports negative net cash after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 4.53% and return on assets (ROA) of 2.67%, both below the industry median for Specialty Chemicals. Operating income of 102.6 million PLN and net income of 61.5 million PLN reflect modest margins, with gross profit at 302.8 million PLN or 16.8% of revenue. These figures suggest underperformance relative to peers in terms of asset efficiency and profitability. The company’s revenue is concentrated across three segments: Chemicals (core polyols and chloralkali production), Energy (electric and thermal energy), and Other Activities (industrial services and waste management). No segment breakdown is provided in the input data, but the lack of geographic diversification and reliance on domestic operations in Poland may expose the company to regional economic risks. Outlook data is not provided in the input, but historical revenue of 1.8 billion PLN and operating cash flow of 295.9 million PLN suggest stable but non-explosive growth. Free cash flow is negative at -23.1 million PLN, driven by capital expenditures of -151.5 million PLN, indicating ongoing investment in operations. Risk factors include medium liquidity risk due to negative net cash and a medium debt load. Dilution risk is low, with no difference between basic and diluted shares outstanding. Analysts have assigned a mean recommendation of 1.50 (leaning toward buy), with a mean price target of 81.78 PLN, suggesting moderate upside potential. Recent events include no disclosed filings or transcripts in the input data, but the company’s capital expenditures and operating cash flow suggest ongoing operational investment and maintenance.

30-day price · PCR+1.20 (+1.8%)
Low$65.90High$71.20Close$68.20As of17 May, 00:00 UTC
Profile
CompanyPCC Rokita SA
TickerPCR.WA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. PCC Rokita SA is a Poland-based company engaged in the chemicals industry, operating through three segments: Chemicals, Energy, and Other Activities, generating revenue primarily from the production and sale of polyols, chloralkali, chlorobenzene, and energy services.

Classification. PCC Rokita is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a confidence level of 0.92 based on verified market data.

PCC Rokita maintains a conservative capital structure with a debt-to-equity ratio of 0.4, below the median for the Specialty Chemicals industry, and a current ratio of 1.47, indicating moderate liquidity. However, the company reports negative net cash after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 4.53% and return on assets (ROA) of 2.67%, both below the industry median for Specialty Chemicals. Operating income of 102.6 million PLN and net income of 61.5 million PLN reflect modest margins, with gross profit at 302.8 million PLN or 16.8% of revenue. These figures suggest underperformance relative to peers in terms of asset efficiency and profitability. The company’s revenue is concentrated across three segments: Chemicals (core polyols and chloralkali production), Energy (electric and thermal energy), and Other Activities (industrial services and waste management). No segment breakdown is provided in the input data, but the lack of geographic diversification and reliance on domestic operations in Poland may expose the company to regional economic risks. Outlook data is not provided in the input, but historical revenue of 1.8 billion PLN and operating cash flow of 295.9 million PLN suggest stable but non-explosive growth. Free cash flow is negative at -23.1 million PLN, driven by capital expenditures of -151.5 million PLN, indicating ongoing investment in operations. Risk factors include medium liquidity risk due to negative net cash and a medium debt load. Dilution risk is low, with no difference between basic and diluted shares outstanding. Analysts have assigned a mean recommendation of 1.50 (leaning toward buy), with a mean price target of 81.78 PLN, suggesting moderate upside potential. Recent events include no disclosed filings or transcripts in the input data, but the company’s capital expenditures and operating cash flow suggest ongoing operational investment and maintenance.
Key takeaways
  • PCC Rokita has a conservative debt-to-equity ratio of 0.4 but faces liquidity constraints due to negative net cash.
  • ROE and ROA are below industry medians, indicating underperformance in asset efficiency and profitability.
  • Revenue is concentrated in three segments, with no geographic diversification reported.
  • Analysts assign a moderate buy rating with a mean price target of 81.78 PLN.
  • Free cash flow is negative due to high capital expenditures, suggesting ongoing investment in operations.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPLN
Revenue$1.80B
Gross profit$302.8M
Operating income$102.6M
Net income$61.5M
R&D
SG&A
D&A
SBC
Operating cash flow$295.9M
CapEx-$151.5M
Free cash flow-$23.1M
Total assets$2.31B
Total liabilities$949.7M
Total equity$1.36B
Cash & equivalents$83.9M
Long-term debt$544.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.36B
Net cash-$460.8M
Current ratio1.5
Debt/Equity0.4
ROA2.7%
ROE4.5%
Cash conversion4.8%
CapEx/Revenue-8.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricPCRActivity
Op margin5.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.4%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin16.8%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity40.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target81.78 PLN
Median price target81.78 PLN
High price target83.87 PLN
Low price target79.70 PLN
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate6.13 PLN
Last actual EPS3.09 PLN
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 17:52 UTC#0d1047ca
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 10:41 UTCJob: 948ee610